CAVEATS IN INTERPRETING AND COMPARING LONG-TERM EFFICACY IN BIOLOGIC STUDIES FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS

被引：0

作者：

Langley, Richard G. ^{[1
]}

Egeberg, Alexander ^{[2
]}

Gooderham, Melinda ^{[3
,4
]}

Bissonnette, Robert ^{[5
]}

Ringuet, Julien ^{[6
]}

Kalia, Sunil ^{[7
]}

Park-Wyllie, Laura ^{[8
]}

Abbarin, Nastaran ^{[8
]}

Tran, Diana ^{[9
]}

Zara, Anthony ^{[9
]}

Yang, Ya-Wen ^{[10
]}

Strober, Bruce ^{[11
,12
]}

机构：

[1] Dalhousie Univ, Halifax, NS, Canada

[2] Bispebjerg Hosp, Copenhagen, Denmark

[3] SKiN Ctr Dermatol & Prob Med Res, Kingston, ON, Canada

[4] Queens Univ, Kingston, ON, Canada

[5] Innovaderm Res Inc, Montreal, PQ, Canada

[6] Ctr Rech Dermatol Quebec Metropolitain CRDQ, Quebec City, PQ, Canada

[7] Univ British Columbia, Vancouver, BC, Canada

[8] Janssen Inc, Toronto, ON, Canada

[9] EVERSA NA, Burlington, ON, Canada

[10] Johnson & Johnson, Janssen Pharmaceut Co, Titusville, NJ USA

[11] Cent Connecticut Dermatol Res, Cromwell, CT USA

[12] Yale Univ, New Haven, CT USA

来源：

ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P-031

引用

页数：102

共 50 条

[21] Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
Sawyer, L. M.
Cornic, L.
Levin, L. A.
Gibbons, C.
Moller, A. H.
Jemec, G. B.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 355 - 366
[22] Biologic treatment sequences in moderate-to-severe psoriasis
Ting, Samantha
Lowe, Patricia
Smith, Annika
Fernandez-Penas, Pablo
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (07) : e178 - e186
[23] Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort
Dalaker, M.
Bonesronning, J. H.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (03) : 277 - 282
[24] Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
April W. Armstrong
Ahmed M. Soliman
Keith A. Betts
Yan Wang
Yawen Gao
Vassilis Stakias
Luis Puig
Dermatology and Therapy, 2022, 12 : 167 - 184
[25] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
Paller, Amy
Seyger, Marieke
Alejandro Magarinos, Gabriel
Bagel, Jerry
Keller, Stuart
Capriles, Claudia Rodriguez
Gallo, Gaia
Edson-Heredia, Emily
Li, Lingnan
Xu, Wen
Papp, Kim
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
[26] Impact of Body Weight on Efficacy of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis
Menter, Alan
Draelos, Zoe
Heim, Jayme
Parno, Jeff
Mendelsohn, Alan
Rozzo, Stephen
Griffiths, Christopher
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[27] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
Emily K. Haque
Aaminah Azhar
John Corbett
Jillian Frieder
Xuan Wang
Alan Menter
Dermatology and Therapy, 2020, 10 : 1121 - 1135
[28] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
Haque, Emily K.
Azhar, Aaminah
Corbett, John
Frieder, Jillian
Wang, Xuan
Menter, Alan
DERMATOLOGY AND THERAPY, 2020, 10 (05) : 1121 - 1135
[29] Sustained long-term Efficacy of Ustekinumab over 3 Years in Patients with moderate to severe Plaque Psoriasis
Ghislain, P-D
Poulin, Y.
Wasel, N.
Menter, A.
Sofen, H.
Yeilding, N.
Fakharzadeh, S.
Li, S.
Leonardi, C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 195 - 195
[30] Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
Frampton, James E.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 295 - 306

← 1 2 3 4 5 →